ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,018Medicare Part D Prescriptions Filled, Including Refills

Rank: 144 out of 5176

$1.1M Total Retail Price of All Prescriptions

Rank: 209 out of 5176

708 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 708 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 708 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 15,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 842 762 1 8
WARFARIN SODIUM 576 510 2 13
SIMVASTATIN 534 454 3 1
LEVOTHYROXINE SODIUM 515 455 4 4
OMEPRAZOLE 480 430 5 3
METOPROLOL TARTRATE 479 434 6 6
AMLODIPINE BESYLATE 459 428 7 2
LISINOPRIL 420 370 8 5
DONEPEZIL HCL 335 334 9 28
CITALOPRAM HBR 326 289 10 31
HYDROCODONE-ACETAMINOPHEN 317 270 S3 11 27
POTASSIUM CHLORIDE 308 290 12 34
QUETIAPINE FUMARATE 275 270 13 75
TRAZODONE HCL 265 227 14 71
MIRTAZAPINE 252 251 15 45
NOVOLOG 245 215 16 168
SERTRALINE HCL 241 224 17 30
GABAPENTIN 230 182 18 21
LOSARTAN POTASSIUM 227 215 19 14
JANTOVEN 224 153 20 106
NAMENDA 217 217 21 47
METOPROLOL SUCCINATE 206 185 22 11
LANTUS 191 161 23 66
TAMSULOSIN HCL 190 178 24 20
METFORMIN HCL 177 167 25 7
ATENOLOL 172 155 26 12
FINASTERIDE 165 165 27 69
ISOSORBIDE MONONITRATE ER 164 153 28 44
CYMBALTA 142 119 29 90
TRAMADOL HCL 139 121 30 40
RISPERIDONE 132 121 31 78
SPIRIVA 129 105 32 54
HYDROCHLOROTHIAZIDE 125 113 33 10
CARVEDILOL 115 103 34 24
ADVAIR DISKUS 114 96 35 32
AZITHROMYCIN 113 105 36 42
CARBIDOPA-LEVODOPA 111 111 37 98
ESCITALOPRAM OXALATE 111 109 37 89
CLOPIDOGREL 108 104 39 26
RANITIDINE HCL 103 99 40 36
PLAVIX 101 85 41 29
POLYETHYLENE GLYCOL 3350 99 92 42 74
OXYBUTYNIN CHLORIDE 94 79 43 227
SANTYL 94 87 43 124
LEVETIRACETAM 93 65 45 92
HYDRALAZINE HCL 92 59 46 73
GLIPIZIDE ER 91 74 47 117
ATORVASTATIN CALCIUM 88 81 48 9
SEROQUEL 87 83 49 166
DIVALPROEX SODIUM 85 64 50 104
OLANZAPINE 82 77 51 140
MELOXICAM 81 81 52 53
NIFEDIPINE ER 76 72 53 48
FAMOTIDINE 75 65 54 58
VENLAFAXINE HCL ER 74 74 55 186
HALOPERIDOL 72 72 56 145
DILTIAZEM 24HR CD 70 47 57 119
OXYCODONE-ACETAMINOPHEN 69 45 S2 58 101
LEVEMIR 67 44 59 252
RAMIPRIL 66 54 60 50
ALBUTEROL SULFATE 65 30 61 99
PAROXETINE HCL 65 55 61 93
METOLAZONE 65 65 61 271
CEPHALEXIN 64 61 64 189
CARBAMAZEPINE 63 60 65 302
TAMIFLU 62 56 66 231
PRAVASTATIN SODIUM 62 55 66 23
DIGOXIN 62 52 66 56
LEXAPRO 61 61 69 193
NYSTATIN 60 55 70 168
CELEBREX 59 43 71 80
LEVOFLOXACIN 58 51 72 109
PREDNISONE 58 56 72 52
NEXIUM 57 41 74 16
LACTULOSE 55 44 75 87
ALLOPURINOL 55 39 75 41
DIOVAN 54 47 77 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 47 77 181
SENSIPAR 53 50 79 357
LYRICA 53 43 79 133
ABILIFY 52 51 81 273
TRAVATAN Z 51 51 82 234
CYCLOBENZAPRINE HCL 50 21 R 83 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.